Jazz Pharmaceuticals PLC (JAZZ)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	4,068,943	3,992,713	3,909,883	3,843,380	3,834,209	3,794,392	3,762,904	3,738,465	3,659,374	3,583,982	3,481,445	3,300,378	3,094,238	2,863,024	2,625,797	2,436,422	2,363,567	2,279,790	2,216,604	2,188,301
Total assets	US$ in thousands	12,012,300	12,255,700	11,361,900	11,327,100	11,393,400	11,204,100	11,260,500	11,047,100	10,835,300	10,384,700	11,200,100	11,768,900	12,298,600	12,478,200	13,213,000	6,756,470	6,535,900	6,291,960	6,066,500	5,215,300
Total asset turnover		0.34	0.33	0.34	0.34	0.34	0.34	0.33	0.34	0.34	0.35	0.31	0.28	0.25	0.23	0.20	0.36	0.36	0.36	0.37	0.42

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $4,068,943K ÷ $12,012,300K
= 0.34

The total asset turnover ratio for Jazz Pharmaceuticals PLC has shown a fluctuating trend over the observed period. The ratio decreased from 0.42 in March 2020 to 0.37 in June 2020 and further declined to 0.36 by September 2020, maintaining the same level for the following quarter. There was a slight increase to 0.36 in March 2021 but then a significant drop to 0.20 by June 2021.

Subsequently, there was a gradual improvement in the total asset turnover ratio, reaching 0.31 by June 2022. The ratio continued to increase, reaching 0.34 by December 2022, where it remained stable for the following three quarters.

Overall, Jazz Pharmaceuticals PLC's total asset turnover indicates the company's efficiency in generating revenue from its total assets. The improvement in the ratio in recent periods suggests a better utilization of assets to generate sales, reflecting positively on the company's operational performance.